List of Tables
Table 1. Global CD20 Target Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CD20 Target Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CD20 Target Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global CD20 Target Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global CD20 Target Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CD20 Target Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CD20 Target Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CD20 Target Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CD20 Target Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CD20 Target Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD20 Target Drug, Product Type & Application
Table 12. Global Key Manufacturers of CD20 Target Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD20 Target Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD20 Target Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD20 Target Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CD20 Target Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global CD20 Target Drug Sales Market Share by Region (2020-2025)
Table 19. Global CD20 Target Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global CD20 Target Drug Sales Market Share by Region (2026-2031)
Table 21. Global CD20 Target Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CD20 Target Drug Revenue Market Share by Region (2020-2025)
Table 23. Global CD20 Target Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CD20 Target Drug Revenue Market Share by Region (2026-2031)
Table 25. North America CD20 Target Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CD20 Target Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America CD20 Target Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America CD20 Target Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CD20 Target Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CD20 Target Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CD20 Target Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe CD20 Target Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe CD20 Target Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CD20 Target Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CD20 Target Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CD20 Target Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific CD20 Target Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific CD20 Target Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CD20 Target Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD20 Target Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CD20 Target Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America CD20 Target Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America CD20 Target Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CD20 Target Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CD20 Target Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CD20 Target Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa CD20 Target Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa CD20 Target Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CD20 Target Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CD20 Target Drug Sales (K Units) by Type (2020-2025)
Table 51. Global CD20 Target Drug Sales (K Units) by Type (2026-2031)
Table 52. Global CD20 Target Drug Sales Market Share by Type (2020-2025)
Table 53. Global CD20 Target Drug Sales Market Share by Type (2026-2031)
Table 54. Global CD20 Target Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CD20 Target Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CD20 Target Drug Revenue Market Share by Type (2020-2025)
Table 57. Global CD20 Target Drug Revenue Market Share by Type (2026-2031)
Table 58. Global CD20 Target Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global CD20 Target Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global CD20 Target Drug Sales (K Units) by Application (2020-2025)
Table 61. Global CD20 Target Drug Sales (K Units) by Application (2026-2031)
Table 62. Global CD20 Target Drug Sales Market Share by Application (2020-2025)
Table 63. Global CD20 Target Drug Sales Market Share by Application (2026-2031)
Table 64. Global CD20 Target Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CD20 Target Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CD20 Target Drug Revenue Market Share by Application (2020-2025)
Table 67. Global CD20 Target Drug Revenue Market Share by Application (2026-2031)
Table 68. Global CD20 Target Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global CD20 Target Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche CD20 Target Drug Product
Table 74. Roche Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi CD20 Target Drug Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Novartis CD20 Target Drug Product
Table 84. Novartis Recent Developments/Updates
Table 85. TG Therapeutics Company Information
Table 86. TG Therapeutics Description and Business Overview
Table 87. TG Therapeutics CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. TG Therapeutics CD20 Target Drug Product
Table 89. TG Therapeutics Recent Developments/Updates
Table 90. AbbVie Company Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. AbbVie CD20 Target Drug Product
Table 94. AbbVie Recent Developments/Updates
Table 95. Genmab Company Information
Table 96. Genmab Description and Business Overview
Table 97. Genmab CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Genmab CD20 Target Drug Product
Table 99. Genmab Recent Developments/Updates
Table 100. PT Kalbe Genexine Biologics Company Information
Table 101. PT Kalbe Genexine Biologics Description and Business Overview
Table 102. PT Kalbe Genexine Biologics CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. PT Kalbe Genexine Biologics CD20 Target Drug Product
Table 104. PT Kalbe Genexine Biologics Recent Developments/Updates
Table 105. Amgen, Inc. Company Information
Table 106. Amgen, Inc. Description and Business Overview
Table 107. Amgen, Inc. CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Amgen, Inc. CD20 Target Drug Product
Table 109. Amgen, Inc. Recent Developments/Updates
Table 110. Pfizer Inc. Company Information
Table 111. Pfizer Inc. Description and Business Overview
Table 112. Pfizer Inc. CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Pfizer Inc. CD20 Target Drug Product
Table 114. Pfizer Inc. Recent Developments/Updates
Table 115. Sandoz, Inc. Company Information
Table 116. Sandoz, Inc. Description and Business Overview
Table 117. Sandoz, Inc. CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sandoz, Inc. CD20 Target Drug Product
Table 119. Sandoz, Inc. Recent Developments/Updates
Table 120. Celltrion, Inc. Company Information
Table 121. Celltrion, Inc. Description and Business Overview
Table 122. Celltrion, Inc. CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Celltrion, Inc. CD20 Target Drug Product
Table 124. Celltrion, Inc. Recent Developments/Updates
Table 125. Biocad Medical, Inc. Company Information
Table 126. Biocad Medical, Inc. Description and Business Overview
Table 127. Biocad Medical, Inc. CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Biocad Medical, Inc. CD20 Target Drug Product
Table 129. Biocad Medical, Inc. Recent Developments/Updates
Table 130. mAbxience SA Company Information
Table 131. mAbxience SA Description and Business Overview
Table 132. mAbxience SA CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. mAbxience SA CD20 Target Drug Product
Table 134. mAbxience SA Recent Developments/Updates
Table 135. Hetero Drugs Ltd. Company Information
Table 136. Hetero Drugs Ltd. Description and Business Overview
Table 137. Hetero Drugs Ltd. CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Hetero Drugs Ltd. CD20 Target Drug Product
Table 139. Hetero Drugs Ltd. Recent Developments/Updates
Table 140. Aryogen Pharmed Company Information
Table 141. Aryogen Pharmed Description and Business Overview
Table 142. Aryogen Pharmed CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Aryogen Pharmed CD20 Target Drug Product
Table 144. Aryogen Pharmed Recent Developments/Updates
Table 145. Biosidus SA Company Information
Table 146. Biosidus SA Description and Business Overview
Table 147. Biosidus SA CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Biosidus SA CD20 Target Drug Product
Table 149. Biosidus SA Recent Developments/Updates
Table 150. Probiomed SA de CV Company Information
Table 151. Probiomed SA de CV Description and Business Overview
Table 152. Probiomed SA de CV CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Probiomed SA de CV CD20 Target Drug Product
Table 154. Probiomed SA de CV Recent Developments/Updates
Table 155. Henlius Company Information
Table 156. Henlius Description and Business Overview
Table 157. Henlius CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Henlius CD20 Target Drug Product
Table 159. Henlius Recent Developments/Updates
Table 160. Innovent Company Information
Table 161. Innovent Description and Business Overview
Table 162. Innovent CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Innovent CD20 Target Drug Product
Table 164. Innovent Recent Developments/Updates
Table 165. CHIATAI TIANOING Company Information
Table 166. CHIATAI TIANOING Description and Business Overview
Table 167. CHIATAI TIANOING CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. CHIATAI TIANOING CD20 Target Drug Product
Table 169. CHIATAI TIANOING Recent Developments/Updates
Table 170. CASI Pharmaceuticals Company Information
Table 171. CASI Pharmaceuticals Description and Business Overview
Table 172. CASI Pharmaceuticals CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. CASI Pharmaceuticals CD20 Target Drug Product
Table 174. CASI Pharmaceuticals Recent Developments/Updates
Table 175. SinoCellTech Company Information
Table 176. SinoCellTech Description and Business Overview
Table 177. SinoCellTech CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. SinoCellTech CD20 Target Drug Product
Table 179. SinoCellTech Recent Developments/Updates
Table 180. BioRay Company Information
Table 181. BioRay Description and Business Overview
Table 182. BioRay CD20 Target Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. BioRay CD20 Target Drug Product
Table 184. BioRay Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. CD20 Target Drug Distributors List
Table 188. CD20 Target Drug Customers List
Table 189. CD20 Target Drug Market Trends
Table 190. CD20 Target Drug Market Drivers
Table 191. CD20 Target Drug Market Challenges
Table 192. CD20 Target Drug Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
Table 196. Authors List of This Report
List of Figures
Figure 1. Product Picture of CD20 Target Drug
Figure 2. Global CD20 Target Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD20 Target Drug Market Share by Type: 2024 & 2031
Figure 4. CD20 Target Product Picture
Figure 5. CD20+CD3 Target Product Picture
Figure 6. Global CD20 Target Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global CD20 Target Drug Market Share by Application: 2024 & 2031
Figure 8. Rheumatoid Arthritis
Figure 9. Chronic Lymphocytic Leukemia
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Global CD20 Target Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global CD20 Target Drug Market Size (2020-2031) & (US$ Million)
Figure 14. Global CD20 Target Drug Sales (2020-2031) & (K Units)
Figure 15. Global CD20 Target Drug Average Price (US$/Unit) & (2020-2031)
Figure 16. CD20 Target Drug Report Years Considered
Figure 17. CD20 Target Drug Sales Share by Manufacturers in 2024
Figure 18. Global CD20 Target Drug Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest CD20 Target Drug Players: Market Share by Revenue in CD20 Target Drug in 2024
Figure 20. CD20 Target Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global CD20 Target Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America CD20 Target Drug Sales Market Share by Country (2020-2031)
Figure 23. North America CD20 Target Drug Revenue Market Share by Country (2020-2031)
Figure 24. United States CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe CD20 Target Drug Sales Market Share by Country (2020-2031)
Figure 27. Europe CD20 Target Drug Revenue Market Share by Country (2020-2031)
Figure 28. Germany CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific CD20 Target Drug Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific CD20 Target Drug Revenue Market Share by Region (2020-2031)
Figure 35. China CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America CD20 Target Drug Sales Market Share by Country (2020-2031)
Figure 43. Latin America CD20 Target Drug Revenue Market Share by Country (2020-2031)
Figure 44. Mexico CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa CD20 Target Drug Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa CD20 Target Drug Revenue Market Share by Country (2020-2031)
Figure 49. Turkey CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE CD20 Target Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of CD20 Target Drug by Type (2020-2031)
Figure 53. Global Revenue Market Share of CD20 Target Drug by Type (2020-2031)
Figure 54. Global CD20 Target Drug Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of CD20 Target Drug by Application (2020-2031)
Figure 56. Global Revenue Market Share of CD20 Target Drug by Application (2020-2031)
Figure 57. Global CD20 Target Drug Price (US$/Unit) by Application (2020-2031)
Figure 58. CD20 Target Drug Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
